FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab)
Go back to FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab)| Regeneron (NASDAQ: REGN) | Delayed: 843.51 +16.87 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $826.64 | 52 Week High | $592.36 | |||
| Open | $835.74 | 52 Week Low | $325.35 | |||
| Day High | $844.06 | P/E | 221.39 | |||
| Day Low | $826.64 | EPS | $3.81 | |||
| Volume | 308,976 | |||||
